Ambulatory clearance function monitor

• US 5,301,673 A
• Filed: 11/18/1991
• Issued: 04/12/1994
• Est. Priority Date: 11/18/1991
• Status: Expired due to Term

• Current Assignee: The General Hospital Corporation (Mass General Brigham, Inc.)
• Original Assignee: Massachusetts General Hospital (Mass General Brigham, Inc.)
• Inventors: Moore, Richard H., Rabito, Carlos A.
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): GILBERT, SAMUEL G
• Application Number:
  US07/793,781
• Time in Patent Office: 876 Days
• Field of Search: 128/654, 128/659, 128/653.1, 128/653.4, 128/662, 128/664, 128/665, 128/633, 354/39, 354/40, 354/41
• US Class Current: 600/436
• CPC Class Codes: A61B 2562/17 Comprising radiolucent components
• CPC Class Codes: A61B 5/00 Measuring for diagnostic purposes radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00; Identification of persons
• CPC Class Codes: A61B 5/412 Detecting or monitoring sepsis
• CPC Class Codes: A61B 5/413 Monitoring transplanted tissue or organ, e.g. for possible rejection reactions after a transplant
• CPC Class Codes: A61B 6/507 for determination of haemodynamic parameters, e.g. perfusion CT
• CPC Class Codes: G01T 1/161 Applications in the field of nuclear medicine, e.g. in vivo counting apparatus for radiation diagnosis A61B6/00

Abstract

Accurate and continuous monitoring of clearance function is obtained by determining the depletion of a labelled substance from the extracellular body fluid using an external monitor which detects label from within a defined tissue volume. The detector of the external monitor is contained within a collimator which functions to both exclude external influences and to functionally isolate the volume of extracellular fluid to be monitored. Also, a method for determining and expressing a clearance function in a subject includes steps of allowing a time sufficient to permit establishment of equilibrium of a detectable substance in the extracellular space in the subject, obtaining first and second measures, at first and second times, of the detectable substance in the extracellular fluid within a defined tissue volume in the subject, and determining the slope of the measures over the time interval.

Claims

1. A method for measuring depletion of a detectable substance from a subject'"'"'s body, comprising

providing a detectable substance to a subject, said detectable substance capable of equilibrating in a subject'"'"'s extracellular fluid,

allowing said detectable substance to equilibrate in said subject'"'"'s extracellular fluid forming equilibrated extracellular fluid,

situating a detector on a portion of said subject'"'"'s body having a defined constant volume of said equilibrated extracellular fluid,

enclosing said detector and said portion of said subject'"'"'s body in a barrier that is substantially opaque to said detectable substance such that only said defined constant volume of said equilibrated extracellular fluid within said body portion is detected by said detector,

measuring a response of said detector to said equilibrated detectable substance, said response indicative of the quantity of said detectable substance within said defined constant volume of said equilibrated extracellular fluid, and

determining the depletion of said detectable substance from a change in quantity of said substance measured within said defined constant volume of said equilibrated extracellular fluid.

3. The method of claim 1 or 2 wherein said substance is detectable by detecting radiation from said detectable substance and wherein the step of situating said detector on the portion of the subject'"'"'s body having a defined constant volume of said equilibrated extracellular fluid, comprises enclosing said detector within the barrier, substantially opaque to said radiation, said barrier having an opening through which said radiation passes to said detector.

4. The method of claim 3 wherein said detectable substance is radioactive and said detector comprises a radiation detector.

2. A method for measuring a clearance function of an organ in a subject, comprising

providing a detectable substance to a subject, said detectable substance capable of equilibrating in a subject'"'"'s extracellular fluid,

allowing said detectable substance to equilibrate in said subject'"'"'s extracellular fluid forming equilibrated extracellular fluid,

situating a detector on a portion of said subject'"'"'s body having a defined, constant volume of said equilibrated extracellular fluid,

enclosing said detector and said portion of said subject'"'"'s body in a barrier that is substantially opaque to said detectable substance such that only said defined constant volume of said equilibrated extracellular fluid within said enclosed body portion is detected by said detector,

measuring a response of said detector to said detectable substance in said equilibrated extracellular fluid, said measured response indicative of the quantity of substance in said defined constant volume of said equilibrated extracellular fluid, and

determining the organ'"'"'s clearance function from a change in quantity of said substance measured within said defined constant volume of said equilibrated extracellular fluid

wherein said detector responds substantially only to said detectable substance within said defined constant volume of said equilibrated extracellular fluid.

5. Apparatus for monitoring depletion of a detectable substance that is equilibrated in a subject'"'"'s extracellular fluid, comprising

a detector capable of responding to radiation from the detectable substance,

a first barrier, substantially opaque to said radiation, enclosing said detector, said first barrier having an opening such that said detector will respond to substantially only the radiation from the detectable substance which enters through said opening,

a second barrier substantially opaque to said radiation, enclosing said first barrier and said detector and for selectively enclosing a portion of a body part of said subject, said body portion having a defined constant volume of the extracellular fluid in which said detectable substance is equilibrated, said second barrier preventing radiation from outside said body portion to be detected by said detector, and

a processing means connected to said detector and physically mounted integrally with at least one of said barriers for determining the depletion of the substance from the defined volume of extracellular fluid.

6. The apparatus of claim 5 wherein said apparatus further comprises a collimator, substantially opaque to said radiation, that surrounds said detector and permits passage of substantially only non-deflected radiation.

7. A method for determining and expressing a clearance function of an organ in a subject, comprising

providing a detectable substance to a subject,

allowing a time sufficient to permit establishment of equilibrium of the detectable substance in extracellular fluid in said subject,

obtaining a first measure at a first time of the equilibrated detectable substance in the extracellular fluid within a defined tissue volume of the subject,

obtaining a second measure at a second time of the equilibrated detectable substance in the extracellular fluid within said defined tissue volume,

determining a slope of the measures over a time interval, and

determining and expressing a clearance function of said subject'"'"'s organ using the slope of the measures to obtain the rate of clearance of the detectable substance from the extracellular fluid by the organ.